Gene · 3416
Papers2,652
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,652
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Deficits of Insulin Signal in Alzheimer's Disease and the Mechanisms of Vanadium Compounds in Curing AD. | Curr Issues Mol Biol | 2023 | 37623221 | PubTator, text mining | PubMed |
| Sex- and APOE-specific genetic risk factors for late-onset Alzheimer's disease: Evidence from gene-gene interaction of longevity-related loci. | Aging Cell | 2023 | 37621137 | PubTator, text mining | PubMed |
| Post-infusion Costs Associated with Idecabtagene Vicleucel Treatment for Patients with Relapsed/Refractory Multiple Myeloma in the KarMMa Trial. | Adv Ther | 2023 | 37597153 | PubTator, text mining | PubMed |
| PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients. | Front Pharmacol | 2023 | 37576821 | PubTator, text mining | PubMed |
| AAV5-mediated manipulation of insulin expression in choroid plexus has long-term metabolic and behavioral consequences. | Cell Rep | 2023 | 37515772 | PubTator, text mining | PubMed |
| Association between polymorphism rs2421943 of the insulin-degrading enzyme and schizophrenia: Preliminary report. | J Clin Lab Anal | 2023 | 37515308 | PubTator, text mining | PubMed |
| Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials. | Int J Mol Sci | 2023 | 37511207 | PubTator, text mining | PubMed |
| Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus. | Int J Mol Sci | 2023 | 37511061 | PubTator, text mining | PubMed |
| Exploring Rosiglitazone's Potential to Treat Alzheimer's Disease through the Modulation of Brain-Derived Neurotrophic Factor. | Biology (Basel) | 2023 | 37508471 | PubTator, text mining | PubMed |
| Analysis of intercellular communication in the osteosarcoma microenvironment based on single cell sequencing data. | J Bone Oncol | 2023 | 37501717 | PubTator, text mining | PubMed |
| T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA. | Curr Opin Oncol | 2023 | 37501530 | PubTator, text mining | PubMed |
| Modulation of the Activity of the Insulin-Degrading Enzyme by Aβ Peptides. | ACS Chem Neurosci | 2023 | 37498802 | PubTator, text mining | PubMed |
| Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice. | Diabetes Obes Metab | 2023 | 37493025 | PubTator, text mining | PubMed |
| Correlation between insulin-degrading enzyme versus total tau and selected cytokines in patients with Alzheimer´s disease compared to non-demented controls. | Neuro Endocrinol Lett | 2023 | 37466059 | PubTator, text mining | PubMed |
| Degradation of amyloid beta species by multi-copper oxidases. | bioRxiv | 2023 | 37461701 | PubTator, text mining | PubMed |
| Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation. | Heliyon | 2023 | 37449101 | PubTator, text mining | PubMed |
| Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2023 | 37445986 | PubTator, text mining | PubMed |
| A State-of-Art Review of the Vicious Circle of Sleep Disorders, Diabetes and Neurodegeneration Involving Metabolism and Microbiota Alterations. | Int J Mol Sci | 2023 | 37445790 | PubTator, text mining | PubMed |
| Therapeutic Candidates for Alzheimer's Disease: Saponins. | Int J Mol Sci | 2023 | 37445682 | PubTator, text mining | PubMed |
| The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms. | Curr Res Pharmacol Drug Discov | 2023 | 37441273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3416/papers?page=9